Omgeo, Enfusion Partner on Listed Derivatives

ted-leveroni-omgeo
Ted Leveroni, Omgeo

The solution, targeted at hedge funds and other alternative managers, will enable firms to centrally match, allocate, and confirm contracts-for-difference, equities, and fixed income transactions. The new offering will also standardize post-trade workflow for ETD trades, and reduce operational risk by supporting both execution and clearing messages at once.

“As hedge funds continue to boost their trading strategies with listed derivatives, they need to ensure their middle- and back-office processes keep pace with their front-office activities. The new joint offering highlights Omgeo’s aim to facilitate efficiency across the evolving global markets, increasing automation and lowering risk for buy- and sell-side firms alike," Ted Leveroni, executive director of derivative strategy at Omgeo, says.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

If M&A picks up, who’s on the auction block?

Waters Wrap: With projections that mergers and acquisitions are geared to pick back up in 2025, Anthony reads the tea leaves of 25 of this year’s deals to predict which vendors might be most valuable.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here